Fumaric Acid Esters Stimulate Astrocytic VEGF Expression through HIF-1α and Nrf2
Open Access
- 3 October 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (10) , e76670
Abstract
Fumaric acid esters (FAE) are oral analogs of fumarate that have recently been shown to decrease relapse rate and disease progression in multiple sclerosis (MS), prompting to investigate their protective potential in other neurological diseases such as amyotrophic lateral sclerosis (ALS). Despite efficacy in MS, mechanisms of action of FAEs are still largely unknown. FAEs are known to activate the transcription factor Nrf2 and downstream anti-oxidant responses through the succination of Nrf2 inhibitor KEAP1. However, fumarate is also a known inhibitor of prolyl-hydroxylases domain enzymes (PhD), and PhD inhibition might lead to stabilization of the HIF-1α transcription factor under normoxic conditions and subsequent activation of a pseudo hypoxic response. Whether Nrf2 activation is associated with HIF-1α stabilization in response to FAEs in cell types relevant to MS or ALS remains unknown. Here, we show that FAEs elicit HIF-1α accumulation, and VEGF release as its expected consequence, in astrocytes but not in other cell types of the central nervous system. Reporter assays demonstrated that increased astrocytic VEGF release in response to FAEs was dependent upon both HIF-1α and Nrf2 activation. Last, astrocytes of transgenic mice expressing SOD1(G93A), an animal model of ALS, displayed reduced VEGF release in response to FAEs. These studies show that FAEs elicit different signaling pathways in cell types from the central nervous system, in particular a pseudo-hypoxic response in astrocytes. Disease relevant mutations might affect this response.Keywords
This publication has 40 references indexed in Scilit:
- Effects of dimethyl fumarate on neuroprotection and immunomodulationJournal of Neuroinflammation, 2012
- Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory diseaseJournal of Clinical Investigation, 2012
- Fumarate Is Cardioprotective via Activation of the Nrf2 Antioxidant PathwayCell Metabolism, 2012
- Overexpression of carbonic anhydrase and HIF-1α in Wilms tumoursBMC Cancer, 2011
- The Anti-Inflammatory Effects of Dimethyl Fumarate in Astrocytes Involve Glutathione and Haem Oxygenase-1ASN Neuro, 2011
- Efficacy of Fumaric Acid Esters in the R6/2 and YAC128 Models of Huntington's DiseasePLOS ONE, 2011
- Effects of mitochondrial dysfunction on the immunological properties of microgliaJournal of Neuroinflammation, 2010
- Extended Ischemia Prevents HIF1α Degradation at Reoxygenation by Impairing Prolyl-hydroxylationJournal of Biological Chemistry, 2010
- Hypoxia potentiates Notch signaling in breast cancer leading to decreased E-cadherin expression and increased cell migration and invasionBritish Journal of Cancer, 2009
- PTEN regulates p300-dependent hypoxia-inducible factor 1 transcriptional activity through Forkhead transcription factor 3a (FOXO3a)Proceedings of the National Academy of Sciences, 2008